355.94M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma.

Similar securities

Based on sector and market capitalization

Report issue